Article Information
History
- May 10, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Aref A. Bin Abdulhak, MD, MSc1,
- Tarek Kashour, MD2,
- Anas Noman, MD3,
- Haytham Tlayjeh, MD4,
- Ala Mohsen, MD5,
- Mouaz H. Al-Mallah, MD, MSc6 and
- Imad M. Tleyjeh, MD, MSc7,8,9,10,*
- 1Swedish Heart and Vascular Institute, Swedish Medical Center, 550 17th Ave Suite 680, Seattle, WA 98122, USA
- 2King Fahad Cardiac Center, College of Medicine, Department of cardiac sciences, King Saud University, Riyadh, Saudi Arabia
- 3Department of Internal Medicine, University of Missouri-Kansas City, Kansas City, MO 64108, USA
- 4Department of Intensive Care, King Abdulaziz Medical City, King Saud bin Abdulaziz for Health Sciences and King Abdullah International Medical Research Center, Riyadh, Saudi Arabia
- 5Louisiana State University Health Science Center, New Orleans, LA 70112, USA
- 6Houston Methodist DeBakey Heart and Vascular Center, Houston, TX 77030, USA
- 7Division of Infectious Diseases, Mayo Clinic, Rochester, MN, USA
- 8Department of Epidemiology, Mayo Clinic, Rochester, MN, USA
- 9Department of Medicine, Infectious Diseases Section, King Fahad Medical City, PO Box 59046, Riyadh 11525, Saudi Arabia
- 10College of Medicine, Al Faisal University, Riyadh, Saudi Arabia
- ↵*Corresponding author:
Imad M. Tleyjeh, MD, MSc, FACP, FIDSA, Professor of Medicine and Epidemiology, Section of Infectious Diseases, King Fahd Medical City, PO Box 59046, Riyadh 11525, Saudi Arabia, Phone: 00966112889999, Email: itlaygeh{at}gmail.com
Posted May 10, 2020.
Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers and Outcome of COVID-19 : A Systematic Review and Meta-analysis
